Monday, May 25, 2020 4:51:36 PM
https://finance.yahoo.com/news/sanofi-sell-regeneron-stake-worth-171733957.html
"The announcement is part of Sanofi Chief Executive Officer Paul Hudson’s revamped strategy. The company said in December that it would end its hunt for new diabetes and heart disease drugs, helping save more than $2 billion, and focus on lucrative areas such as oncology. Deals would be the fastest way to build up its stable of medicines in cancer, analysts at HSBC said last year."
Bill
Recent SESN News
- Carisma Therapeutics Reports Second Quarter 2023 Financial Results and Recent Business Highlights • PR Newswire (US) • 08/10/2023 11:30:00 AM
Bantec Reports an Over 50 Percent Increase in Sales and Profits in Q1 2024 from Q1 2023 • BANT • Apr 25, 2024 10:00 AM
Cannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA • BLO • Apr 25, 2024 8:52 AM
Kona Gold Beverages, Inc. Announces Name Change to NuVibe, Inc. and Initiation of Ticker Symbol Application Process • KGKG • Apr 25, 2024 8:30 AM
Axis Technologies Group and Carbonis Forge Ahead with New Digital Carbon Credit Technology • AXTG • Apr 24, 2024 3:00 AM
North Bay Resources Announces Successful Equipment Test at Bishop Gold Mill, Inyo County, California • NBRI • Apr 23, 2024 9:41 AM
Epazz, Inc.: CryObo, Inc. solar Bitcoin operations will issue tokens • EPAZ • Apr 23, 2024 9:20 AM